RT Journal Article SR Electronic T1 Association between maternal obesity and metabolic disorders and congenital heart defects in the offspring: a literature review JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.06.25.20140186 DO 10.1101/2020.06.25.20140186 A1 Gitte Hedermann A1 Paula L Hedley A1 Ida N Thagaard A1 Lone Krebs A1 Thorkild IA Sørensen A1 Charlotte Kvist Ekelund A1 Michael Christiansen YR 2020 UL http://medrxiv.org/content/early/2020/06/26/2020.06.25.20140186.abstract AB Congenital heart defects (CHDs) are the most common congenital malformation and will, in severe cases, have a serious impact on neonatal mortality and morbidity. The aetiology of CHDs is complex. Large cohort studies have reported an association between increased risk of CHDs in the offspring and individual maternal metabolic disorders such as diabetes, hypertension, preeclampsia, and obesity. All conditions that can be related to insulin resistance and possibly metabolic syndrome (MetS). The aim of this review is to evaluate the existing evidence on the association between maternal metabolic disorders, defined as obesity, diabetes, hypertension, preeclampsia, dyslipidaemia, and MetS, or combinations thereof and CHDs in the offspring. A literature search was performed using PubMed and Embase databases. Of the 2,076 potentially relevant identified studies, 30 qualified for inclusion. Only one study dealt with the combination of more than one maternal metabolic condition as risk factor for CHDs in the offspring. All other studies investigated the individual metabolic disorders and their association with CHDs. Some disorders (chronic hypertension, gestational diabetes, and obesity) increased risk of CHDs marginally whereas pregestational diabetes and early-onset preeclampsia were highly associated with CHDs. Future studies on the combination of several metabolic disorders in the same pregnancy and their association with CHDs are needed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by The Danish Children Heart Foundation (18-R109-A5193-26043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethical approval was nescessary for this literature review.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data available on request to corresponding author.CHDscongenital heart defectsMetSmetabolic syndromePEpreeclampsiaBMIbody mass indexGDMgestational diabetesDM2diabetes type 2DM1diabetes type 1ICD-10International Classification of Diseases 10th revisionNOSNewcastle-Ottawa ScaleORodds ratiosRRrelative risksPRprevalence ratiosCI95% confidence intervalaOR/aRR/aPRadjustedAVSDatrioventricular septal defectsRVOTOright ventricular outflow tract obstructionVSDventricular septal defectsASDatrial septal defectNBDPSNational Birth Defects Prevention StudyCoAcoarctation of the aorta